Literature DB >> 20551725

Diagnosis of fibromyalgia syndrome-a comparison of Association of the Medical Scientific Societies in Germany, survey, and American College of Rheumatology criteria.

Winfried Häuser1, Sebastian Hayo, Werner Biewer, Mechthild Gesmann, Hedi Kühn-Becker, Frank Petzke, Hubertus von Wilmoswky, Jost Langhorst.   

Abstract

OBJECTIVES: The survey and the Association of the Medical Scientific Societies in Germany (AWMF) criteria had been developed to overcome problems associated with tender point criterion of the American College of Rheumatology (ACR) (lacking validation for clinical diagnosis, inconsistent use by rheumatologists, and nonrheumatologists) for the clinical diagnosis of fibromyalgia syndrome (FMS). We compared the concordance between these 3 criteria.
METHODS: Consecutive patients of different clinical settings referred for the evaluation of chronic widespread pain or management of established FMS diagnosis were assessed by medical history, a complete physical examination including tender points, and questionnaires [self-constructed symptoms questionnaire, regional pain scale (RPS), Patient Health Questionnaire (PHQ 9 and 15)]. FMS according to AWMF-criteria was diagnosed by the history of widespread pain (axial and all 4 extremities), the symptoms sleep disturbances, fatigue, and feeling of swelling or stiffness of the hands or feet or face (Numeric rating scale >or=1/10 each symptom) and the exclusion of somatic diseases sufficiently explaining the symptoms. FMS according to survey criteria was diagnosed by regional pain scale score >or=8 and fatigue score >or=6/10 on a visual analogue scale.
RESULTS: Out of 310 patients, 292 could be analysed. AWMF and ACR were concordant in 86.6%, AWMF and survey criteria were concordant in 78.8% and survey and ACR-criteria were concordant in 79.5% of the cases. DISCUSSION: AWMF, survey, and ACR criteria were moderately concordant. As AWMF and survey criteria do not require tender point examination, these criteria can be used by nonrheumatologists for the clinical diagnosis of FMS.

Entities:  

Mesh:

Year:  2010        PMID: 20551725     DOI: 10.1097/AJP.0b013e3181d92a6c

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  15 in total

Review 1.  Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jost Langhorst; Petra Klose; Gustav J Dobos; Kathrin Bernardy; Winfried Häuser
Journal:  Rheumatol Int       Date:  2012-02-15       Impact factor: 2.631

2.  [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].

Authors:  W Eich; W Häuser; B Arnold; W Jäckel; M Offenbächer; F Petzke; M Schiltenwolf; M Settan; C Sommer; T Tölle; N Uçeyler; P Henningsen
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

Review 3.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

4.  [Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties].

Authors:  A Galek; B Erbslöh-Möller; V Köllner; H Kühn-Becker; J Langhorst; F Petermann; U Prothmann; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

Review 5.  WITHDRAWN: Anticonvulsants for fibromyalgia.

Authors:  Nurcan Üçeyler; Claudia Sommer; Brian Walitt; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2017-10-09

Review 6.  Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome.

Authors:  Geoffrey Littlejohn
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

7.  The German fibromyalgia consumer reports - a cross-sectional survey.

Authors:  Winfried Häuser; Eva Jung; Brigitte Erbslöh-Möller; Mechthild Gesmann; Hedi Kühn-Becker; Franz Petermann; Jost Langhorst; Reinhard Thoma; Thomas Weiss; Frederick Wolfe; Andreas Winkelmann
Journal:  BMC Musculoskelet Disord       Date:  2012-05-18       Impact factor: 2.362

8.  Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey.

Authors:  Winfried Häuser; Eva Jung; Brigitte Erbslöh-Möller; Mechthild Gesmann; Hedi Kühn-Becker; Franz Petermann; Jost Langhorst; Thomas Weiss; Andreas Winkelmann; Frederick Wolfe
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 9.  Cognitive behavioural therapies for fibromyalgia.

Authors:  Kathrin Bernardy; Petra Klose; Angela J Busch; Ernest H S Choy; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2013-09-10

Review 10.  A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome.

Authors:  Romy Lauche; Holger Cramer; Winfried Häuser; Gustav Dobos; Jost Langhorst
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.